38
Views
1
CrossRef citations to date
0
Altmetric
Original articles

Mirtazapine for anorexia nervosa with depression

, , &
Pages 768-769 | Received 25 May 2007, Published online: 06 Jul 2009
 

Abstract

Objective: To report the use of Mirtazapine in the treatment of anorexia nervosa with depression primarily regarding its propensity for weight gain.

Method: We present an outpatient case report of anorexia nervosa with depression. The patient's subsequent progress was recorded.

Results: The patient gained 2.5 kg within 3 months to eventually attain a body mass index of 15 after 5 months. Her depression achieved full remission at 6 weeks of treatment.

Conclusions: Mirtazapine is the choice medication in this case. However, treating depression requires caution, given these patients’ physical vulnerability. Controlled trials of Mirtazapine for anorexia nervosa are needed.

Log in via your institution

Log in to Taylor & Francis Online

There are no offers available at the current time.

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.